MLYSMineralys Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 18633
Ticker: MLYS
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2023-02-10
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MLYS

Detail

Enriched 2026-08-14 20:47

Market cap: $2,391,406,239.25
Shares outstanding (class): 82,498,101
Shares outstanding (weighted): 88,406,885
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 76
Location: RADNOR, PA
Homepage: https://mineralystx.com
Description: Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Market cap and share counts drift.

Funds holding this security

109 funds · 109 positions · $263.06M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$48.07M	0.00%	1,774,478 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$48.04M	0.65%	1,773,248 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$31.67M	0.04%	1,168,887 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$16.67M	0.02%	615,524 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$14.17M	0.11%	523,132 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$11.91M	0.15%	439,648 NS	FIGI
SMALLCAP World Fund Inc SMALLCAP World Fund Inc	—	$10.79M	0.01%	398,179 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$10.56M	0.09%	389,753 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$10.40M	0.13%	383,929 NS	FIGI
Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC	—	$8.13M	0.04%	300,000 NS	FIGI
VIP Health Care Portfolio Variable Insurance Products Fund IV	—	$4.74M	0.47%	175,000 NS	FIGI
Small Cap Core Portfolio Bernstein Fund Inc	—	$3.52M	0.49%	129,995 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$3.24M	0.27%	119,472 NS	FIGI
Small-Cap Growth Portfolio PACIFIC SELECT FUND	—	$2.18M	0.49%	80,350 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$2.07M	0.04%	76,562 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMLYS
FIGI_COMPOSITEBBG00ZXN1GN3
FIGI_SHARE_CLASSBBG00ZXN1GR9
CIK0001933414
ISINUS6031701013
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: SIC 2834 indicates pharmaceutical preparations, so the security is an equity in the healthcare sector.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.